BACKGROUND: Endocrine-disrupting chemicals (EDCs) can target immune and metabolic pathways. However, few epidemiologic studies have examined the influence of EDCs on measures of inflammation and cellular aging during pregnancy and postpartum.

OBJECTIVE: We investigated associations between prenatal exposures to polybrominated diphenyl ethers (PBDEs), hydroxylated PBDE metabolites (OH-PBDEs), polychlorinated biphenyls (PCBs), and per- and polyfluorochemicals (PFASs) with repeated biomarker measurements of inflammation and cellular aging in women during pregnancy and the postpartum period.

METHODOLOGY: Overweight or obese pregnant women were recruited from the San Francisco Bay area (n = 103) during their first or second trimester of pregnancy. Blood samples were collected from participants at baseline (median 16 weeks gestation) and at three and nine months postpartum. Serum concentrations of PBDEs, OH-PBDEs, PCBs, and PFASs were measured at baseline. Inflammation biomarkers (interleukin 6 [IL-6], interleukin 10 [IL-10], and tumor necrosis factor [TNF-α]) and leukocyte telomere length (LTL), a biomarker of cellular aging, were measured at all three time points. Associations between serum chemical concentrations and repeated measures of IL-6, IL-10, TNF-α, and LTL were examined using linear mixed models. We also examined the potential for effect modification by time (visit) and obesity.

RESULTS: In adjusted models, we observed positive relationships between PBDEs and pro-inflammatory cytokines (IL-6 and TNF-α). A doubling in ∑PBDEs was associated with a 15.26% (95% CI 1.24, 31.22) and 3.74% (95% CI -0.19, 7.82) increase in IL-6 and TNF-α, respectively. Positive associations were also observed for PFASs and IL-6. A two-fold increase in ∑PFASs was associated with a 20.87% (95% CI 3.46, 41.22) increase in IL-6. 5-OHBDE-47 was inversely associated with anti-inflammatory cytokine IL-10. Some EDC-outcome associations, including those of PBDEs with TNF-α, were stronger during pregnancy (compared to three or nine months postpartum) and among obese (compared to overweight) women (p-interaction <0.05).

CONCLUSIONS: These findings suggest that exposure to specific EDCs is associated with increased inflammation among women during pregnancy and the postpartum period. Future studies should replicate these findings in additional study populations and examine the implications of these associations for maternal and child health.

[Untagged]
━ New Studies (6/2023)
━ ━ Met PECO
━ ━ ━ Human
━ ━ Supplemental
━ ━ ━ Mechanistic, including non-PECO routes of exposure
━ ━ ━ ADME
━ ━ ━ PFAS mixture
━ ━ ━ Exposure only
━ ━ ━ Ecotoxicity
━ ━ ━ Environmental fate or occurrence
━ ━ ━ Manufacturing, engineering or lab methods
━ ━ ━ Other assessments or records
━ ━ Excluded - Not Meeting PECO
━ Inclusion
━ ━ Human Study
━ ━ Animal Study
━ ━ In vitro (genotox)
━ Exclusion
━ ━ Tier I
━ ━ Tier III
━ PFAS
━ ━ PFBS
━ ━ PFNA
━ ━ PFDA
━ ━ PFHxS
━ ━ PFHxA
━ ━ PFBA
━ Health Outcome
━ ━ acute Toxicity/Poisoning
━ ━ ADME/toxicokinetic
━ ━ body weight
━ ━ cancer
━ ━ cardiovascular
━ ━ clinical chemistry/biochemical/cytotoxicity/cellular function
━ ━ endocrine (hormone)
━ ━ gastrointestinal
━ ━ gene expression/omics
━ ━ genotoxicity
━ ━ growth (early life) and development
━ ━ hematological
━ ━ hepatic
━ ━ immune/inflammation
━ ━ mortality
━ ━ musculoskeletal/motor function
━ ━ neurological/behavior
━ ━ nutrition and metabolic
━ ━ ocular and sensory
━ ━ PBPK model
━ ━ PPAR
━ ━ renal
━ ━ reproductive
━ ━ respiratory
━ ━ sensory
━ ━ skin and connective tissues
━ ━ susceptible population
━ ━ thyroid

References (517 found)